Dataset from Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接:
https://doi.org/10.25934/PR00008029
下载链接
链接失效反馈官方服务:
资源简介:
Food allergy occurs when the immune system reacts against foods. The immune system is the
part of the body that protects us from illness and germs, but it can also cause allergies.
Peanut allergy occurs in 1 - 2% of people in the United States and other Western countries.
There is proof that allergy to peanut is increasing. Allergic reactions to peanut can be
severe and life threatening. The only way that you can prevent an allergic reaction is to
avoid exposure to peanuts. However, peanut proteins are found in a variety of foods and
people can be accidently exposed to peanut proteins. Treatment for accidental exposure
include antihistamines (medications like Benadryl), and injectable epinephrine (adrenalin)
which must be carried at all times. DBV Technologies has developed an epicutaneous delivery
system, a patch that puts the peanut protein on the skin.
创建时间:
2026-02-06



